BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37777411)

  • 1. Comprehensive analysis of NT5DC family-based prognostic model in osteosarcoma.
    Chang X; Jiang Y; Wang Z; Lou Z
    Asian J Surg; 2024 Jan; 47(1):531-532. PubMed ID: 37777411
    [No Abstract]   [Full Text] [Related]  

  • 2. NPRL2 is an independent prognostic factor of osteosarcoma.
    Gao Y; Wang J; Fan G
    Cancer Biomark; 2012-2013; 12(1):31-6. PubMed ID: 23321467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High grade osteosarcoma. Clinico-pathological aspects and molecular prognostic factors.
    Tirabosco R
    Clin Biochem; 2014 Jun; 47(9):735-6. PubMed ID: 24854682
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic role of cytovillin expression in patients with osteosarcoma: a meta-analysis.
    Guo S; Bai R; Zhao W; Wang Y; Zhao Z; Feng W
    Tumour Biol; 2014 Jan; 35(1):469-73. PubMed ID: 23959472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of NT5DC family prognostic and immune significance in breast cancer.
    Jia Y; Li J; Wu H; Wang W; Sun S; Feng C; Liu X; Li C; Zhang Y; Cai Y; Wei X; Yao P; Liu X; Zhang S; Wu F
    Medicine (Baltimore); 2023 Feb; 102(6):e32927. PubMed ID: 36820551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inversion (6)(p23q15) as the sole anomaly in a low-grade intraosseous osteosarcoma.
    Grubb G; Hoctor V; Venter D; Choong P
    Cancer Genet Cytogenet; 1999 Feb; 109(1):70-1. PubMed ID: 9973963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Historical, current and future aspects of osteosarcoma treatment.
    Ham SJ; Schraffordt Koops H; van der Graaf WT; van Horn JR; Postma L; Hoekstra HJ
    Eur J Surg Oncol; 1998 Dec; 24(6):584-600. PubMed ID: 9870738
    [No Abstract]   [Full Text] [Related]  

  • 8. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
    Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
    BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prognostic model based on the integrin genes for osteosarcoma.
    Zhang J; Cheng Z; Chang X; Wang S
    Asian J Surg; 2023 Dec; 46(12):5609-5611. PubMed ID: 37591750
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytogenetics and molecular biology of osteosarcoma.
    Ragland BD; Bell WC; Lopez RR; Siegal GP
    Lab Invest; 2002 Apr; 82(4):365-73. PubMed ID: 11950895
    [No Abstract]   [Full Text] [Related]  

  • 11. DNA ploidy as a prognostic indicator in human osteosarcoma.
    Gebhardt MC; Lew RA; Bell RS; Baldini N; Litwak G; Mankin HJ
    Chir Organi Mov; 1990; 75(1 Suppl):18-21. PubMed ID: 2249526
    [No Abstract]   [Full Text] [Related]  

  • 12. The prognostic value of elevated ezrin in patients with osteosarcoma.
    Lun DX; Hu YC; Xu ZW; Xu LN; Wang BW
    Tumour Biol; 2014 Feb; 35(2):1263-6. PubMed ID: 24014052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of DNA ploidy pattern in osteosarcomas in association with chemotherapy.
    Kusuzaki K; Takeshita H; Murata H; Hirata M; Hashiguchi S; Ashihara T; Hirasawa Y
    Cancer Lett; 1999 Mar; 137(1):27-33. PubMed ID: 10376791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDR1 gene expression and outcome in osteosarcoma: a prospective, multicenter study.
    Wunder JS; Bull SB; Aneliunas V; Lee PD; Davis AM; Beauchamp CP; Conrad EU; Grimer RJ; Healey JH; Rock MJ; Bell RS; Andrulis IL
    J Clin Oncol; 2000 Jul; 18(14):2685-94. PubMed ID: 10894867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a prognostic risk score model based on the ARHGAP family to predict the survival of osteosarcoma.
    Liu W; Xia K; Zheng D; Huang X; Wei Z; Wei Z; Guo W
    BMC Cancer; 2023 Dec; 23(1):1179. PubMed ID: 38041020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Analysis of Key mRNAs and lncRNAs in Osteosarcoma Response to Preoperative Chemotherapy with Prognostic Values.
    Li M; Cheng WT; Li H; Zhang Z; Lu XL; Deng SS; Li J; Yang CH
    Curr Med Sci; 2021 Oct; 41(5):916-929. PubMed ID: 34671904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAFB Promotes Cancer Stemness and Tumorigenesis in Osteosarcoma through a Sox9-Mediated Positive Feedback Loop.
    Chen Y; Wang T; Huang M; Liu Q; Hu C; Wang B; Han D; Chen C; Zhang J; Li Z; Liu C; Lei W; Chang Y; Wu M; Xiang D; Chen Y; Wang R; Huang W; Lei Z; Chu X
    Cancer Res; 2020 Jun; 80(12):2472-2483. PubMed ID: 32234710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-expression of lncRNA FER1L4 might be a prognostic marker in osteosarcoma.
    Chen ZX; Chen CP; Zhang N; Wang TX
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2310-2314. PubMed ID: 29762833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter regarding "Prognostic role of cytovillin expression in patients with osteosarcoma: a meta-analysis" by Guo et al.
    Wang P; Sun L; Yu L; Wang H
    Tumour Biol; 2014 Jul; 35(7):6175. PubMed ID: 24504679
    [No Abstract]   [Full Text] [Related]  

  • 20. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma.
    Lei T; Qian H; Lei P; Hu Y
    Cancer Sci; 2021 Nov; 112(11):4785-4798. PubMed ID: 34506683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.